OPKO HEALTH INC (OPK) Fundamental Analysis & Valuation

NASDAQ:OPK • US68375N1037

Current stock price

1.23 USD
+0.01 (+0.82%)
At close:
1.2204 USD
-0.01 (-0.78%)
After Hours:

This OPK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. OPK Profitability Analysis

1.1 Basic Checks

  • OPK had negative earnings in the past year.
  • OPK had a negative operating cash flow in the past year.
  • In the past 5 years OPK always reported negative net income.
  • In the past 5 years OPK reported 4 times negative operating cash flow.
OPK Yearly Net Income VS EBIT VS OCF VS FCFOPK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • The Return On Assets of OPK (-11.68%) is worse than 76.00% of its industry peers.
  • OPK's Return On Equity of -17.80% is on the low side compared to the rest of the industry. OPK is outperformed by 66.00% of its industry peers.
Industry RankSector Rank
ROA -11.68%
ROE -17.8%
ROIC N/A
ROA(3y)-7.83%
ROA(5y)-7.98%
ROE(3y)-11.76%
ROE(5y)-11.62%
ROIC(3y)N/A
ROIC(5y)N/A
OPK Yearly ROA, ROE, ROICOPK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5 -10 -15 -20

1.3 Margins

  • With a decent Gross Margin value of 33.93%, OPK is doing good in the industry, outperforming 69.00% of the companies in the same industry.
  • OPK's Gross Margin has declined in the last couple of years.
  • OPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.74%
GM growth 5Y-2.08%
OPK Yearly Profit, Operating, Gross MarginsOPK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. OPK Health Analysis

2.1 Basic Checks

  • OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OPK has more shares outstanding
  • The number of shares outstanding for OPK has been increased compared to 5 years ago.
  • OPK has a better debt/assets ratio than last year.
OPK Yearly Shares OutstandingOPK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
OPK Yearly Total Debt VS Total AssetsOPK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • OPK has an Altman-Z score of -0.61. This is a bad value and indicates that OPK is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.61, OPK is doing worse than 80.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.27 indicates that OPK is not too dependend on debt financing.
  • OPK has a Debt to Equity ratio of 0.27. This is in the better half of the industry: OPK outperforms 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z -0.61
ROIC/WACCN/A
WACC9.57%
OPK Yearly LT Debt VS Equity VS FCFOPK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • OPK has a Current Ratio of 3.97. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of OPK (3.97) is better than 91.00% of its industry peers.
  • OPK has a Quick Ratio of 3.52. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of OPK (3.52) is better than 87.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.52
OPK Yearly Current Assets VS Current LiabilitesOPK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. OPK Growth Analysis

3.1 Past

  • The earnings per share for OPK have decreased strongly by -42.86% in the last year.
  • Looking at the last year, OPK shows a very negative growth in Revenue. The Revenue has decreased by -14.90% in the last year.
  • Measured over the past years, OPK shows a very negative growth in Revenue. The Revenue has been decreasing by -15.82% on average per year.
EPS 1Y (TTM)-42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)-14.9%
Revenue growth 3Y-15.45%
Revenue growth 5Y-15.82%
Sales Q2Q%-19.12%

3.2 Future

  • OPK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.06% yearly.
  • OPK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.85% yearly.
EPS Next Y6.21%
EPS Next 2Y7.63%
EPS Next 3Y20.06%
EPS Next 5YN/A
Revenue Next Year-7.84%
Revenue Next 2Y-1.99%
Revenue Next 3Y0.55%
Revenue Next 5Y2.85%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OPK Yearly Revenue VS EstimatesOPK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
OPK Yearly EPS VS EstimatesOPK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.1 -0.2 -0.3 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. OPK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OPK. In the last year negative earnings were reported.
  • Also next year OPK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPK Price Earnings VS Forward Price EarningsOPK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPK Per share dataOPK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • OPK's earnings are expected to grow with 20.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.63%
EPS Next 3Y20.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OPK Dividend Analysis

5.1 Amount

  • OPK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OPK Fundamentals: All Metrics, Ratios and Statistics

OPKO HEALTH INC

NASDAQ:OPK (4/24/2026, 8:00:48 PM)

After market: 1.2204 -0.01 (-0.78%)

1.23

+0.01 (+0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)04-28
Inst Owners26.82%
Inst Owner Change0.62%
Ins Owners5.39%
Ins Owner Change0.02%
Market Cap933.66M
Revenue(TTM)606.88M
Net Income(TTM)-225.68M
Analysts80
Price Target3.47 (182.11%)
Short Float %8.73%
Short Ratio13.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)104.13%
Min EPS beat(2)42.24%
Max EPS beat(2)166.01%
EPS beat(4)2
Avg EPS beat(4)24.47%
Min EPS beat(4)-65.99%
Max EPS beat(4)166.01%
EPS beat(8)5
Avg EPS beat(8)34.69%
EPS beat(12)7
Avg EPS beat(12)33.79%
EPS beat(16)8
Avg EPS beat(16)-93.4%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-6.58%
Max Revenue beat(2)5.21%
Revenue beat(4)1
Avg Revenue beat(4)-4.33%
Min Revenue beat(4)-9.64%
Max Revenue beat(4)5.21%
Revenue beat(8)2
Avg Revenue beat(8)-1.79%
Revenue beat(12)6
Avg Revenue beat(12)3.34%
Revenue beat(16)7
Avg Revenue beat(16)2.37%
PT rev (1m)-4.45%
PT rev (3m)-7.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.67%
EPS NY rev (1m)-2.63%
EPS NY rev (3m)-7.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 12.9
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.8
BVpS1.67
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -11.68%
ROE -17.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.93%
FCFM N/A
ROA(3y)-7.83%
ROA(5y)-7.98%
ROE(3y)-11.76%
ROE(5y)-11.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.74%
GM growth 5Y-2.08%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.4%
Cap/Sales 2.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.97
Quick Ratio 3.52
Altman-Z -0.61
F-Score5
WACC9.57%
ROIC/WACCN/A
Cap/Depr(3y)18.11%
Cap/Depr(5y)23.58%
Cap/Sales(3y)2.47%
Cap/Sales(5y)2.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next Y6.21%
EPS Next 2Y7.63%
EPS Next 3Y20.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.9%
Revenue growth 3Y-15.45%
Revenue growth 5Y-15.82%
Sales Q2Q%-19.12%
Revenue Next Year-7.84%
Revenue Next 2Y-1.99%
Revenue Next 3Y0.55%
Revenue Next 5Y2.85%
EBIT growth 1Y19.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.85%
EBIT Next 3Y34.09%
EBIT Next 5Y25.75%
FCF growth 1Y8.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.7%
OCF growth 3YN/A
OCF growth 5YN/A

OPKO HEALTH INC / OPK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OPKO HEALTH INC?

ChartMill assigns a fundamental rating of 3 / 10 to OPK.


What is the valuation status of OPKO HEALTH INC (OPK) stock?

ChartMill assigns a valuation rating of 1 / 10 to OPKO HEALTH INC (OPK). This can be considered as Overvalued.


How profitable is OPKO HEALTH INC (OPK) stock?

OPKO HEALTH INC (OPK) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for OPK stock?

The Earnings per Share (EPS) of OPKO HEALTH INC (OPK) is expected to grow by 6.21% in the next year.